Colorectal Cancer Liver Metastases Clinical Trial
Official title:
Multimodal Deep Learning Radiomic Nomogram for Evaluation of Response to Cetuximab in Patient With Colorectal Cancer Liver Metastasis
Establishment and validation of the deep learning model of Cetuximab efficacy in simultaneous RAS wild unresectable CRLM patients
Ras wild unresectable CRLM patients with primary tumor resection followed by Cetuximab in combination with chemotherapy were included in this study. The tumor response was assessed by local MDT group. Based on tumor response, almost 100 CRLM patients were classified into two groups (Clinician drived regimen vs Multi-omics model drived regimen). They will be the prospective cohort to validate our deep learning model for predicting Cetuximab efficacy. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT05588297 -
Preoperative Nivolumab Plus Bevacizumab Combined With Chemotherapy Before Surgery in Patients With pMMR/MSS Colorectal Cancer Liver Metastases
|
Phase 2 | |
| Active, not recruiting |
NCT04272931 -
DRAGON 1- Training, Accreditation, Implementation and Safety Evaluation of Combined PVE/HVE
|
N/A | |
| Completed |
NCT02086656 -
PERIOPERATIVE TREATMENT WITH COI-B (CAPECITABINE, OXALIPLATIN, IRINOTECAN AND BEVACIZUMAB) OF HIGH RISK OR BORDERLINE RESECTABLE COLORECTAL CANCER LIVER METASTASES
|
Phase 2 | |
| Recruiting |
NCT05794971 -
Regorafenib Combined With Irinotecan Drug-Eluting Beads for Colorectal Cancer Liver Metastases
|
Phase 3 | |
| Recruiting |
NCT05485909 -
Phase II Study of Regorafenib and Toripalimab Combined With RFA in Patients With CRCLM
|
Phase 2 | |
| Active, not recruiting |
NCT03326791 -
Aspirin in Colorectal Cancer Liver Metastases
|
Phase 2/Phase 3 |